mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.8 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.018 |
0.8 |